Is the Brazilian Pharmaceutical Policy Ensuring Population Access to Essential Medicines?

Overview

Journal Global Health

Publisher Biomed Central

Specialties Health Services
Public Health

Date 2012 Mar 23

PMID 22436555

Citations 23

Authors

Andrea Damaso Bertoldi

Ana Paula Helfer

Aline L Camargo

Noemia U L Tavares

Panos Kanavos

Affiliations

Soon will be listed here.

Abstract

Background: To evaluate medicine prices, availability and affordability in Brazil, considering the differences across three types of medicines (originator brands, generics and similar medicines) and different types of facilities (private pharmacies, public sector pharmacies and "popular pharmacies").

Methods: Data on prices and availability of 50 medicines were collected in 56 pharmacies across six cities in Southern Brazil using the World Health Organization / Health Action International methodology. Median prices obtained were divided by international reference prices to derive the median price ratio (MPR).

Results: In the private sector, prices were 8.6 MPR for similar medicines, 11.3 MRP for generics and 18.7 MRP for originator brands, respectively. Mean availability was 65%, 74% and 48% for originator brands, generics and similar medicines, respectively. In the public sector, mean availability of similar medicines was 2-7 times higher than that of generics. Mean overall availability in the public sector ranged from 68.8% to 81.7%. In "popular pharmacies", mean availability was greater than 90% in all cities.

Conclusions: Availability of medicines in the public sector does not meet the challenge of supplying essential medicines to the entire population, as stated in the Brazilian constitution. This has unavoidable repercussions for affordability, particularly amongst the lower socio-economic strata.

Citing Articles

Practices in the prescription of antiseizure medications: is it time to change?.

Pinto L, Silva L, Joao R, Boldrini V, Cendes F, Yasuda C Arq Neuropsiquiatr. 2024; 82(6):1-10.

PMID: 38531396 PMC: 10965294. DOI: 10.1055/s-0043-1777806.

The internationalization of TCM towards Portuguese-speaking countries.

Zheng X, Lyu L, Lu H, Hu Y, Chan G Chin Med. 2021; 16(1):81.

PMID: 34412664 PMC: 8374110. DOI: 10.1186/s13020-021-00491-6.

Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.

Osuafor N, Ukwe C, Okonta M PLoS One. 2021; 16(8):e0255567.

PMID: 34383799 PMC: 8360378. DOI: 10.1371/journal.pone.0255567.

Availability of Essential Medicines in a Country in Conflict: A Quantitative Insight from Yemen.

Ibrahim M, Alshakka M, Al-Abd N, Bahattab A, Badulla W Int J Environ Res Public Health. 2021; 18(1).

PMID: 33383771 PMC: 7795412. DOI: 10.3390/ijerph18010175.

Consumption and Lack of Access to Medicines and Associated Factors in the Brazilian Amazon: A Cross-Sectional Study, 2019.

Tiguman G, Silva M, Galvao T Front Pharmacol. 2020; 11:586559.

PMID: 33123016 PMC: 7573467. DOI: 10.3389/fphar.2020.586559.

References

Miranda E, Santos Pinto C, dos Reis A, Emmerick I, Campos M, Luiza V . [Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil]. Cad Saude Publica. 2009; 25(10):2147-58. DOI: 10.1590/s0102-311x2009001000006. View

Guerra Jr A, de Assis Acurcio F, Gomes C, Miralles M, Girardi S, Werneck G . [Availability of essential drugs in two regions of Minas Gerais, Brazil]. Rev Panam Salud Publica. 2004; 15(3):168-75. DOI: 10.1590/s1020-49892004000300005. View

Babar Z, Ibrahim M, Singh H, Bukahri N, Creese A . Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLoS Med. 2007; 4(3):e82. PMC: 1831730. DOI: 10.1371/journal.pmed.0040082. View

Viacava F, de Souza-Junior P, Szwarcwald C . Coverage of the Brazilian population 18 years and older by private health plans: an analysis of data from the World Health Survey. Cad Saude Publica. 2006; 21 Suppl:119-28. DOI: 10.1590/s0102-311x2005000700013. View

Dos Santos V, Nitrini S . [Prescription and patient-care indicators in healthcare services]. Rev Saude Publica. 2004; 38(6):819-26. DOI: 10.1590/s0034-89102004000600010. View

Cheraghali A, Idries A . Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci. 2009; 31(2):209-15. DOI: 10.1007/s11096-009-9282-3. View

Vieira F, Zucchi P . [Price differences between generic and innovator medicines in Brazil]. Rev Saude Publica. 2006; 40(3):444-9. DOI: 10.1590/s0034-89102006000300012. View

Du Bocage Santos-Pinto C, Costa N, Osorio-de-Castro C . [The "Farmácia Popular do Brasil" Program and aspects of public provision of medicines in Brazil]. Cien Saude Colet. 2011; 16(6):2963-73. DOI: 10.1590/s1413-81232011000600034. View

Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi P, Patel A . Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res. 2007; 125(5):645-54. View

10.

Naves J, Silver L . [Evaluation of pharmaceutical assistance in public primary care in Brasilia, Brazil]. Rev Saude Publica. 2005; 39(2):223-30. DOI: 10.1590/s0034-89102005000200013. View

11.

Vieira M, Lorandi P, Bousquat A . [Assessment of pharmaceutical care for pregnant women treated in the public health system in Praia Grande, São Paulo State, Brazil]. Cad Saude Publica. 2008; 24(6):1419-28. DOI: 10.1590/s0102-311x2008000600022. View

12.

Bertoldi A, Barros A, Hallal P . Generic drugs in Brazil: known by many, used by few. Cad Saude Publica. 2006; 21(6):1808-15. DOI: 10.1590/s0102-311x2005000600029. View

13.

Yang H, Dib H, Zhu M, Qi G, Zhang X . Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health Policy Plan. 2009; 25(3):219-29. DOI: 10.1093/heapol/czp056. View

14.

Niens L, Cameron A, Van de Poel E, Ewen M, Brouwer W, Laing R . Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010; 7(8). PMC: 2930876. DOI: 10.1371/journal.pmed.1000333. View

15.

Paniz V, Fassa A, Facchini L, Bertoldi A, Piccini R, Tomasi E . [Access to continuous-use medication among adults and the elderly in South and Northeast Brazil]. Cad Saude Publica. 2008; 24(2):267-80. DOI: 10.1590/s0102-311x2008000200005. View

16.

Vieira F, Zucchi P . Resource allocation for pharmaceutical procurement in the Brazilian Unified Health System. Rev Saude Publica. 2011; 45(5):906-13. DOI: 10.1590/s0034-89102011005000048. View

17.

Bertoldi A, Barros A, Camargo A, Hallal P, Vandoros S, Wagner A . Household expenditures for medicines and the role of free medicines in the Brazilian public health system. Am J Public Health. 2010; 101(5):916-21. PMC: 3076418. DOI: 10.2105/AJPH.2009.175844. View

18.

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R . Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008; 373(9659):240-9. DOI: 10.1016/S0140-6736(08)61762-6. View

19.

Bertoldi A, Barros A, Wagner A, Ross-Degnan D, Hallal P . Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2008; 89(3):295-302. DOI: 10.1016/j.healthpol.2008.07.001. View

20.

Barros A, Bertoldi A . Out-of-pocket health expenditure in a population covered by the Family Health Program in Brazil. Int J Epidemiol. 2008; 37(4):758-65. DOI: 10.1093/ije/dyn063. View